Skip to main content
Clinical Trials/NCT05483166
NCT05483166
Recruiting
N/A

Engaging Parents in Neuropsychological Rehabilitation for Childhood Cancer Survivors: The "I'm Aware: Parents and Children Together" (ImPACT) Program - A Pilot Study

Aarhus University Hospital1 site in 1 country10 target enrollmentOctober 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pediatric Cancer
Sponsor
Aarhus University Hospital
Enrollment
10
Locations
1
Primary Endpoint
Parent-reported neurobehavioral functioning
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The aim of the present pilot study is to evaluate the feasibility, acceptability, and preliminary efficacy of a novel, context-sensitive neuropsychological rehabilitation intervention for childhood cancer survivors and their families.

Detailed Description

Cognitive impairment is the most common late effect in childhood cancer survivors, and despite the negative effects of these symptoms on quality of life, scholastic achievement and long-term socioeconomic outcomes, there continues to be no "gold standard" treatment for childhood cancer survivors with cognitive impairment. Indeed, there is a dearth of research on interventions to treat cognitive impairment in childhood cancer survivors, and the relatively few studied interventions have proven limited effects. Arguably, four key elements are missing from a majority of studied interventions:1) transfer of learning to real-world functional outcomes, 2) awareness training to enhance compensatory strategy use, 3) inclusion of parents that could enhance transfer of learning to the home, and 4) recognition of the inter-related nature of cognitive, neurobehavioral, and psychological functions. The "I'M aware: Parents and Children Together (ImPACT)" program is a novel, context-sensitive neuropsychological rehabilitation intervention that targets the above mentioned missing elements in previous rehabilitation efforts. The present pilot study aims to assess the feasibility, acceptability, and preliminary efficacy of this program in childhood cancer survivors with cognitive impairment in preparation for a large-scale randomized controlled trial.

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
December 1, 2026
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Aarhus University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Lisa Maria Wu

Associate Professor

University of Aarhus

Eligibility Criteria

Inclusion Criteria

  • Cancer diagnosis of a leukemia, lymphoma, or central nervous system tumor
  • Completed primary treatment at least 6 months ago
  • Not terminally ill
  • Attend school
  • Living with one or more parents who speak Danish and are willing to co-participate
  • Screened as having parent-reported cognitive and/or neurobehavioral impairment

Exclusion Criteria

  • Confounding diagnosed or suspected psychiatric or medical condition unrelated to the cancer or its treatment that might contribute to cognitive or neurobehavioral impairment

Outcomes

Primary Outcomes

Parent-reported neurobehavioral functioning

Time Frame: Baseline (T1) to after last session (approximately 9 weeks later: Post-intervention, T3)

The parent-report screening version of the Behavior Rating Inventory of Executive Function 2nd Edition (BRIEF-2). 12 items: answer format range: 1-3; total score range: 12-36. Higher score indicates more impairment.

Parent-reported cognitive functioning

Time Frame: Baseline (T1) to after last session (approximately 9 weeks later: Post-intervention, T3)

The parent-report version of the Pediatric Perceived Cognitive Function (PedsPCF) Short Form. 7 items: answer format range 1-5; total score range: 7-35. Lower score indicates more impairment.

Secondary Outcomes

  • Child-reported pediatric fatigue(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Parent-reported pediatric anxiety and depression(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Parent-reported neurobehavioral functioning(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Parent-reported cognitive functioning(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Child-reported neurobehavioral functioning(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Child-reported cognitive functioning(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Child-reported pediatric quality of life(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Parent sense of competence(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Child-reported participant motivation(After last session (approximately 9 weeks after Baseline assessment (T1): Post-intervention, T3)))
  • Objective cognitive functioning (Child only)(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Parent-reported pediatric quality of life(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Child-reported pediatric anxiety and depression(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Parent-reported pediatric fatigue(Baseline (T1) to 9 week after post-intervention (approximately 18 weeks later: Follow-up, T4))
  • Parent-reported participant motivation(After last session (approximately 9 weeks after Baseline assessment (T1): Post-intervention, T3))
  • Parent-reported participant satisfaction(After last session (approximately 9 weeks after Baseline assessment (T1): Post-intervention, T3))
  • Child-reported participant satisfaction(After last session (approximately 9 weeks after Baseline assessment (T1): Post-intervention, T3))

Study Sites (1)

Loading locations...

Similar Trials